In this study, we analyzed gene expression data and corresponding clinical information for BC from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases to identify corresponding TFs and eligible patients and to explore the utility of a TF signature for BC prognosis. Here, TF is linked to breast cancer.